Page last updated: 2024-11-05

trihexyphenidyl and Malaria, Falciparum

trihexyphenidyl has been researched along with Malaria, Falciparum in 1 studies

Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.

Malaria, Falciparum: Malaria caused by PLASMODIUM FALCIPARUM. This is the severest form of malaria and is associated with the highest levels of parasites in the blood. This disease is characterized by irregularly recurring febrile paroxysms that in extreme cases occur with acute cerebral, renal, or gastrointestinal manifestations.

Research Excerpts

ExcerptRelevanceReference
" Following an evaluation by the psychiatrist, a diagnosis of catatonic schizophrenia was made and he was started on oral sulpiride and benhexol."3.79Neuroleptic malignant syndrome masked by cerebral malaria. ( Rajesh, KM; Sakthi, AN; Sinnathamby, V, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rajesh, KM1
Sinnathamby, V1
Sakthi, AN1

Other Studies

1 other study available for trihexyphenidyl and Malaria, Falciparum

ArticleYear
Neuroleptic malignant syndrome masked by cerebral malaria.
    BMJ case reports, 2013, May-22, Volume: 2013

    Topics: Adult; Antipsychotic Agents; Delayed Diagnosis; Fatal Outcome; Humans; Malaria, Cerebral; Malaria, F

2013